Year |
Citation |
Score |
2021 |
Yu KJ, Hsu WL, Chiang CJ, Chen TC, Liu Z, Lou PJ, Diehl S, Goldstein AM, Chen CJ, Wang CP, Hildesheim A. Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years. Cancer. PMID 34324707 DOI: 10.1002/cncr.33799 |
0.354 |
|
2020 |
Lee MH, Huang YH, Coghill AE, Liu Z, Yu KJ, Hsu WL, Chien YC, Wang CP, Chen TC, Chen CJ, Hildesheim A. Epstein-Barr Virus (EBV) Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores are Elevated in NPC Multiplex Family Members Compared to the General Population in Taiwan. The Journal of Infectious Diseases. PMID 32614957 DOI: 10.1093/Infdis/Jiaa385 |
0.43 |
|
2020 |
Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ, Lou PJ, Wang CP, Liu Z, Chen CJ, Middeldorp J, et al. Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 26: 3496. PMID 32611629 DOI: 10.1158/1078-0432.Ccr-20-1828 |
0.384 |
|
2020 |
Petrick JL, Florio AA, Koshiol J, Pfeiffer RM, Yang B, Yu K, Chen CJ, Yang HI, Lee MH, McGlynn KA. Prediagnostic Concentrations of Circulating Bile Acids and Hepatocellular Carcinoma Risk: REVEAL-HBV and HCV Studies. International Journal of Cancer. PMID 32406072 DOI: 10.1002/Ijc.33051 |
0.326 |
|
2020 |
Simon J, Liu Z, Brenner N, Yu KJ, Hsu WL, Wang CP, Chien YC, Coghill AE, Chen CJ, Butt J, Proietti C, Doolan DL, Hildesheim A, Waterboer T. Validation of an EBV Antibody Risk Stratification Signature for Nasopharyngeal Carcinoma using Multiplex serology. Journal of Clinical Microbiology. PMID 32102852 DOI: 10.1128/Jcm.00077-20 |
0.382 |
|
2020 |
Hsu WL, Chien YC, Huang YT, Yu KJ, Ko JY, Lin CY, Tsou YA, Leu YS, Liao LJ, Chang YL, Su JY, Liu Z, Wang CP, Terng SD, Hua CH, et al. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis. Cancer Medicine. PMID 31925935 DOI: 10.1002/Cam4.2832 |
0.339 |
|
2020 |
Starrett GJ, Yu K, Petersen D, Lenz P, Dyrskjøt L, Meltzer P, Engels E, Buck CB. Abstract IA11: Bladder cancers affecting transplant recipients harbor diverse viruses that associate with overall survival Cancer Research. 80. DOI: 10.1158/1538-7445.Mvc2020-Ia11 |
0.311 |
|
2019 |
Liu Z, Jarrett RF, Hjalgrim H, Proietti C, Chang ET, Smedby KE, Yu KJ, Lake A, Troy S, McAulay KA, Pfeiffer RM, Adami HO, Glimelius B, Melbye M, Hildesheim A, et al. Evaluation of the antibody response to the EBV proteome in EBV-associated classic Hodgkin lymphoma. International Journal of Cancer. PMID 31618442 DOI: 10.1002/Ijc.32741 |
0.344 |
|
2019 |
Liu Z, Yu KJ, Coghill AE, Brenner N, Cao SM, Chen CJ, Chen Y, Doolan DL, Hsu WL, Labo N, Middeldorp JM, Miley W, Simon J, Wang CP, Waterboer T, et al. Multi-laboratory assessment of EBV serologic assays: the case for standardization. Journal of Clinical Microbiology. PMID 31434722 DOI: 10.1128/Jcm.01107-19 |
0.306 |
|
2019 |
Yu G, Hsu WL, Coghill AE, Yu KJ, Wang CP, Lou PJ, Liu Z, Jones K, Vogt A, Wang M, Mbulaiteye SM, Chen HH, Boland J, Yeager M, Diehl SR, et al. Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma. Scientific Reports. 9: 9916. PMID 31289279 DOI: 10.1038/S41598-019-46137-4 |
0.404 |
|
2019 |
Liu Z, Goldstein AM, Hsu WL, Yu KJ, Chien YC, Ko JY, Jian JJ, Tsou YA, Leu YS, Liao LJ, Chang YL, Wang CP, Wu JS, Hua CH, Lee JC, ... ... Yu K, et al. Evaluation of rare and common variants from suspected familial or sporadic nasopharyngeal carcinoma (NPC) susceptibility genes in sporadic NPC. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31270100 DOI: 10.1158/1055-9965.Epi-19-0007 |
0.384 |
|
2018 |
Coghill AE, Hsu WL, Yang Q, Wang CP, Lou PJ, Yu KJ, Yu G, Diehl SR, Chen CJ, Goldstein AM, Hildesheim A. Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants. The Journal of General Virology. PMID 29975184 DOI: 10.1099/Jgv.0.001115 |
0.426 |
|
2018 |
Coghill AE, Bu W, Hsu WL, Nguyen H, Yu KJ, Chien YC, Chen CJ, Cohen JI, Hildesheim A. Evaluation of total and IgA-specific antibody targeting Epstein-Barr virus glycoprotein 350 and nasopharyngeal carcinoma risk. The Journal of Infectious Diseases. PMID 29718378 DOI: 10.1093/Infdis/Jiy250 |
0.423 |
|
2018 |
Liu Z, Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Yu KJ, Lou PJ, Wang CP, Mulvenna J, Middeldorp JM, Bethony J, Chen CJ, et al. Patterns of inter-individual variability in the antibody repertoire targeting proteins across the Epstein-Barr virus proteome. The Journal of Infectious Diseases. PMID 29509907 DOI: 10.1093/Infdis/Jiy122 |
0.329 |
|
2018 |
Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ, Lou PJ, Wang CP, Liu Z, Chen CJ, Middeldorp JM, et al. Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29301829 DOI: 10.1158/1078-0432.Ccr-17-1929 |
0.415 |
|
2017 |
Coghill AE, Wang CP, Verkuijilen SAWM, Yu KJ, Hsu WL, Middeldorp JM, Hildesheim A. Evaluation of Nasal and Nasopharyngeal Swab Collection for the Detection of Epstein-Barr Virus in Nasopharyngeal Carcinoma. Journal of Medical Virology. PMID 28833336 DOI: 10.1002/Jmv.24918 |
0.328 |
|
2016 |
Pinsky PF, Prorok PC, Yu K, Kramer BS, Black A, Gohagan JK, Crawford ED, Grubb RL, Andriole GL. Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years. Cancer. PMID 27911486 DOI: 10.1002/Cncr.30474 |
0.312 |
|
2016 |
Zhu CS, Huang WY, Pinsky PF, Berg CD, Sherman M, Yu KJ, Carrick DM, Black A, Hoover R, Lenz P, Williams C, Hawkins L, Chaloux M, Yurgalevitch S, Mathew S, et al. The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27635065 DOI: 10.1158/1055-9965.Epi-16-0506 |
0.327 |
|
2016 |
Pinsky PF, Yu K, Kramer BS, Black A, Buys SS, Partridge E, Gohagan J, Berg CD, Prorok PC. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up. Gynecologic Oncology. PMID 27615399 DOI: 10.1016/J.Ygyno.2016.08.334 |
0.313 |
|
2016 |
Liu Z, Coghill AE, Pfeiffer RM, Hsu WL, Lou PJ, Wang CP, Yu KJ, Niwa S, Brotzman M, Ye W, Chen CJ, Hildesheim A. Birth order and risk of nasopharyngeal carcinoma in multiplex families from Taiwan. International Journal of Cancer. PMID 27537611 DOI: 10.1002/Ijc.30390 |
0.43 |
|
2016 |
Coghill AE, Bu W, Nguyen H, Hsu WL, Yu KJ, Lou PJ, Wang CP, Chen CJ, Hildesheim A, Cohen JI. High levels of antibody that neutralize B-cell infection of Epstein-Barr virus and that bind EBV gp350 are associated with a lower risk of nasopharyngeal carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26920891 DOI: 10.1158/1078-0432.Ccr-15-2299 |
0.398 |
|
2015 |
Black A, Huang WY, Wright P, Riley T, Mabie J, Mathew S, Ragard L, Hermansen S, Yu K, Pinsky P, Prorok PC, Freedman ND, Hoover RN. PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies. Reviews On Recent Clinical Trials. 10: 238-45. PMID 26435289 DOI: 10.2174/157488711003150928130654 |
0.349 |
|
2015 |
Schoen RE, Razzak A, Yu KJ, Berndt SI, Firl K, Riley TL, Pinsky PF. Incidence and Mortality of Colorectal Cancer in Individuals With a Family History of Colorectal Cancer. Gastroenterology. PMID 26255045 DOI: 10.1053/J.Gastro.2015.07.055 |
0.393 |
|
2015 |
Carrick DM, Black A, Gohagan JK, Khan A, Pettit K, Williams C, Yu K, Yurgalevitch S, Huang WY, Zhu C. The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource. Reviews On Recent Clinical Trials. PMID 26238117 DOI: 10.2174/1574887110666150730121429 |
0.331 |
|
2015 |
Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC. Data Processing and Analytic Support in the PLCO Cancer Screening Trial. Reviews On Recent Clinical Trials. PMID 26238116 DOI: 10.2174/1574887110666150730122723 |
0.304 |
|
2015 |
Hirt C, Camargo MC, Yu KJ, Hewitt SM, Dölken G, Rabkin CS. Risk of follicular lymphoma associated with BCL2 translocations in peripheral blood. Leukemia & Lymphoma. 1-5. PMID 25549806 DOI: 10.3109/10428194.2014.999324 |
0.309 |
|
2014 |
Coghill AE, Hsu WL, Pfeiffer RM, Juwana H, Yu KJ, Lou PJ, Wang CP, Chen JY, Chen CJ, Middeldorp JM, Hildesheim A. Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1213-9. PMID 24769890 DOI: 10.1158/1055-9965.Epi-13-1262 |
0.436 |
|
2014 |
Hsu WL, Chien YC, Chiang CJ, Yang HI, Lou PJ, Wang CP, Yu KJ, You SL, Wang LY, Chen SY, Yang CS, Chen CJ. Lifetime risk of distinct upper aerodigestive tract cancers and consumption of alcohol, betel and cigarette. International Journal of Cancer. Journal International Du Cancer. 135: 1480-6. PMID 24535776 DOI: 10.1002/Ijc.28791 |
0.316 |
|
2014 |
Razzak A, Yu K, Pinsky P, Riley T, Schoen RE. 939 Association Between Family History of Colorectal Cancer and Incident Colorectal Cancer in the PLCO Trial Gastroenterology. 146: S-162-S-163. DOI: 10.1016/S0016-5085(14)60581-3 |
0.372 |
|
2013 |
Chang C, Middeldorp J, Yu KJ, Juwana H, Hsu WL, Lou PJ, Wang CP, Chen JY, Liu MY, Pfeiffer RM, Chen CJ, Hildesheim A. Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma. Journal of Medical Virology. 85: 524-9. PMID 23280934 DOI: 10.1002/Jmv.23498 |
0.435 |
|
2012 |
Hsu WL, Pan WH, Chien YC, Yu KJ, Cheng YJ, Chen JY, Liu MY, Hsu MM, Lou PJ, Chen IH, Yang CS, Hildesheim A, Chen CJ. Lowered risk of nasopharyngeal carcinoma and intake of plant vitamin, fresh fish, green tea and coffee: a case-control study in Taiwan. Plos One. 7: e41779. PMID 22848600 DOI: 10.1371/Journal.Pone.0041779 |
0.313 |
|
2012 |
Gao Y, Baccarelli A, Shu XO, Ji BT, Yu K, Tarantini L, Yang G, Li HL, Hou L, Rothman N, Zheng W, Gao YT, Chow W. Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women's Health Study British Journal of Cancer. 106: 585-591. PMID 22173668 DOI: 10.1038/Bjc.2011.562 |
0.346 |
|
2012 |
Chang CM, Yu KJ, Hsu WL, Major JM, Chen JY, Lou PJ, Liu MY, Diehl SR, Goldstein AM, Chen CJ, Hildesheim A. Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families. British Journal of Cancer. 106: 206-9. PMID 22095229 DOI: 10.1038/Bjc.2011.502 |
0.364 |
|
2012 |
Hirt C, Meier M, Yu K, Schüler F, Janz S, Dölken G, Rabkin CS. Abstract 1672: Population prevalence of consensus translocations in follicular and mantle cell lymphomas Cancer Research. 72: 1672-1672. DOI: 10.1158/1538-7445.Am2012-1672 |
0.333 |
|
2011 |
Yu KJ, Hsu WL, Pfeiffer RM, Chiang CJ, Wang CP, Lou PJ, Cheng YJ, Gravitt P, Diehl SR, Goldstein AM, Chen CJ, Hildesheim A. Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1906-14. PMID 21447725 DOI: 10.1158/1078-0432.Ccr-10-1681 |
0.594 |
|
2011 |
Hsu WL, Yu KJ, Chien YC, Chiang CJ, Cheng YJ, Chen JY, Liu MY, Chou SP, You SL, Hsu MM, Lou PJ, Wang CP, Hong JH, Leu YS, Tsai MH, et al. Familial tendency and risk of nasopharyngeal carcinoma in taiwan: effects of covariates on risk. American Journal of Epidemiology. 173: 292-9. PMID 21148719 DOI: 10.1093/Aje/Kwq358 |
0.437 |
|
2009 |
Yu KJ, Gao X, Chen CJ, Yang XR, Diehl SR, Goldstein A, Hsu WL, Liang XS, Marti D, Liu MY, Chen JY, Carrington M, Hildesheim A. Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. Human Immunology. 70: 910-4. PMID 19683024 DOI: 10.1016/J.Humimm.2009.08.005 |
0.36 |
|
2009 |
Chang CM, Yu KJ, Mbulaiteye SM, Hildesheim A, Bhatia K. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Research. 143: 209-21. PMID 19596032 DOI: 10.1016/J.Virusres.2009.07.005 |
0.339 |
|
2009 |
Yu KJ, Rader JS, Borecki I, Zhang Z, Hildesheim A. CD83 polymorphisms and cervical cancer risk. Gynecologic Oncology. 114: 319-22. PMID 19446866 DOI: 10.1016/J.Ygyno.2009.04.033 |
0.374 |
|
2009 |
Yu KJ, Hsu WL, Chiang CJ, Cheng YJ, Pfeiffer RM, Diehl SR, Goldstein AM, Gravitt PE, Chen CJ, Hildesheim A. Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan. International Journal of Cancer. Journal International Du Cancer. 124: 1622-5. PMID 19065653 DOI: 10.1002/Ijc.24051 |
0.593 |
|
2007 |
Yu KJ, Bashirova A, Madeleine MM, Cheng J, Johnson LG, Schwartz SM, Carrington M, Hildesheim A. Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2504-8. PMID 18006945 DOI: 10.1158/1055-9965.Epi-07-0261 |
0.377 |
|
Show low-probability matches. |